The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Computation of key characteristics and plots for blinded sample size recalculation. Continuous as well as binary endpoints are supported in superiority and non-inferiority trials. See Baumann, Pilz, Kieser (2022) <doi:10.32614/RJ-2022-001> for a detailed description. The implemented methods include the approaches by Lu, K. (2019) <doi:10.1002/pst.1737>, Kieser, M. and Friede, T. (2000) <doi:10.1002/(SICI)1097-0258(20000415)19:7%3C901::AID-SIM405%3E3.0.CO;2-L>, Friede, T. and Kieser, M. (2004) <doi:10.1002/pst.140>, Friede, T., Mitchell, C., Mueller-Veltern, G. (2007) <doi:10.1002/bimj.200610373>, and Friede, T. and Kieser, M. (2011) <doi:10.3414/ME09-01-0063>.
Version: | 1.0.1 |
Imports: | methods, Rcpp |
LinkingTo: | Rcpp |
Suggests: | testthat, covr |
Published: | 2023-10-04 |
DOI: | 10.32614/CRAN.package.blindrecalc |
Author: | Lukas Baumann |
Maintainer: | Lukas Baumann <baumann at imbi.uni-heidelberg.de> |
License: | MIT + file LICENSE |
URL: | https://github.com/imbi-heidelberg/blindrecalc |
NeedsCompilation: | yes |
Citation: | blindrecalc citation info |
Materials: | README NEWS |
CRAN checks: | blindrecalc results |
Reference manual: | blindrecalc.pdf |
Package source: | blindrecalc_1.0.1.tar.gz |
Windows binaries: | r-devel: blindrecalc_1.0.1.zip, r-release: blindrecalc_1.0.1.zip, r-oldrel: blindrecalc_1.0.1.zip |
macOS binaries: | r-release (arm64): blindrecalc_1.0.1.tgz, r-oldrel (arm64): blindrecalc_1.0.1.tgz, r-release (x86_64): blindrecalc_1.0.1.tgz, r-oldrel (x86_64): blindrecalc_1.0.1.tgz |
Old sources: | blindrecalc archive |
Please use the canonical form https://CRAN.R-project.org/package=blindrecalc to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.